During the past decade, Aliae Mohamed-Hussein conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aliae Mohamed-Hussein" are "Covid19" (2 trials), "Coronavirus Disease" (1 trials), "Global Impact" (1 trials), "Post COVID-19" (1 trials) and "Pulmonology" (1 trials). Many other conditions were trialed in "Aliae Mohamed-Hussein" in a lesser frequency.

Most popular intervention types in "Aliae Mohamed-Hussein" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Kaplan Meier analysis" (1 trials), "Montelukast Sodium Tablets" (1 trials) and "Survey" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aliae Mohamed-Hussein" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Aliae Mohamed-Hussein". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Aliae Mohamed-Hussein, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aliae Mohamed-Hussein, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".